47.44
-2.85 (-5.67%)
-2.85 (-5.67%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -2.85 | -5.67% | 47.44 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 47.63 | 46.57 | 49.85 | 47.44 | 50.29 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 41.55 | 72.00 | 30.45 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,801 | 1,153,449 | $ 47.45 | $ 54,728,449 | 1,035,052 | 27.774 - 58.93 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:46:14 | 18 | $ 47.50 | USD |
Agios Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.29B | 69.26M | 44.78M | $ 117.91M | $ - | -6.86 | -9.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 50.70 | 55.25 | 46.57 | 52.81 | 673,595 | -3.26 | -6.43% |
| 1 Month | 45.88 | 58.93 | 45.45 | 53.22 | 675,018 | 1.56 | 3.4% |
| 3 Months | 45.56 | 58.93 | 32.47 | 44.80 | 872,315 | 1.88 | 4.13% |
| 6 Months | 38.51 | 58.93 | 32.47 | 41.78 | 755,000 | 8.93 | 23.19% |
| 1 Year | 47.12 | 58.93 | 27.774 | 43.16 | 713,485 | 0.32 | 0.68% |
| 3 Years | 83.25 | 99.8242 | 27.774 | 50.35 | 595,805 | -35.81 | -43.02% |
| 5 Years | 37.50 | 99.8242 | 27.774 | 51.35 | 601,900 | 9.94 | 26.51% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
